Free Trial
→ Strange: Why is Amazon suddenly yielding 39.70%? (From Investors Alley) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 15 of 15

Slide 15
Back to 14
Next Slideshow
 
Back to 14
Next Slideshow
 

Vaxcyte (NASDAQ:PCVX)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$147.50 (69.9% Upside)

About Vaxcyte

Vaxcyte logoVaxcyte, Inc, a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/6/2024Cantor FitzgeraldReiterated RatingOverweight
11/6/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$140.00 ➝ $140.00
9/10/2024MizuhoBoost Price TargetOutperform ➝ Outperform$113.00 ➝ $163.00
9/4/2024Bank of AmericaBoost Price TargetBuy ➝ Buy$101.00 ➝ $140.00
9/3/2024Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$108.00 ➝ $129.00
9/3/2024Leerink PartnersBoost Price TargetOutperform ➝ Outperform$106.00 ➝ $153.00
9/3/2024BTIG ResearchBoost Price TargetBuy ➝ Buy$98.00 ➝ $160.00
9/3/2024Needham & Company LLCBoost Price TargetBuy ➝ Buy$95.00 ➝ $140.00
8/7/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$95.00 ➝ $95.00
6/28/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$95.00 ➝ $95.00

More Investing Slideshows:

Slide 15
Back to 14
Next Slideshow
 

Let’s be blunt (Ad)

Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!

Check out the $100 Challenge now

More From MarketBeat
Bill Gates’s Next Big AI Bet: Stargate
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...
Brownstone Research | Sponsored
7 Restaurant Stocks to Profit from the Trend Towards Fast Casual
If you're a data-driven investor, you may be surprised to learn that fast-casual restaurant stocks are some of...
MarketBeat
The Crypto That’s Making Wall Street Sweat
The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...
Crypto 101 Media | Sponsored
7 Infrastructure Stocks to Buy Like There's No Tomorrow
Members of Congress agree on very few things. But in the last four years, there has been bipartisan support fo...
MarketBeat
There is a little known company that is changing warfare
With geo - political instability around the world investors are flocking to defense contract stocks. There...
Reticulate | Sponsored
7 Stocks with Recent Downgrades Worth a Second Look
Analyst ratings can be a key piece of information that investors look for in stock evaluation. Typically, anal...
MarketBeat